Kirkland & Ellis is representing Edding Group Company Limited on the transaction, and Haiwen is representing Genor Biopharma. Edding Group Company Limited agreed to acquire Genor...
Genor Biopharma’s Merger with Edding
Synagistics’ De-SPAC Transaction with HK Acquisition Corporation
Freshfields Bruckhaus Deringer advised Synagistics Pte. Ltd on the transaction, and Kirkland & Ellis advised Celestial Link Limited. Synagistics Pte. Ltd (‘Synagistics’) announced its proposed de-SPAC...
Yitai Coal’s Buy-back and Delisting of H Shares
Kirkland & Ellis advised China International Capital Corporation Hong Kong Securities Limited (CICC) on the deal. Inner Mongolia Yitai Coal Co., Ltd. has announced its proposal to buy-back...
Gravitas Education Holdings’ Acquisition of eLMTree
Skadden is serving as U.S. legal counsel to a special committee of the board of directors of Gravitas, Cleary Gottlieb is serving as U.S. legal counsel to...
Power Heritage Group’s HK$1.291 Billion Proposed Privatization of Jiangnan Group
Kirkland & Ellis advised Power Heritage Group Limited on the deal. The respective directors of Power Heritage Group Limited and Jiangnan Group jointly announced that on 16 February...
Skyworth Group’s HK$380 Million Share Buy-Back Offer
Kirkland & Ellis advised Skyworth Group Limited on the deal. Skyworth Group Limited (HKSE: 00751) announced its HK$380 million voluntary conditional cash offer to buy-back a...